Roedl, Kevin
Wolfrum, Sebastian
Michels, Guido
Pin, Martin
Söffker, Gerold
Janssens, Uwe
Kluge, Stefan
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 12 December 2022
Accepted: 11 January 2023
First Online: 23 January 2023
Declarations
:
: The study was approved by the local clinical institutional review board and complies with the Declaration of Helsinki. This study was approved by the local ethics committee (2022-300183-WF).
: Not applicable.
: KR, SW, MP, GS and UJ declare that they have no competing interests. GM received lecture honoraria from Getinge and Orion Pharma. SK received research support from Cytosorbents and Daiichi Sankyo. He also received lecture fees from ADVITOS, Biotest, Daiichi Sankyo, Fresenius Medical Care, Gilead, Mitsubishi Tanabe Pharma, MSD, Pfizer and Zoll. He received consultant fees from Fresenius, Gilead, MSD and Pfizer.